Drugs / Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules
Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05776940 Comparator | Mar 2023 → Mar 2026 | AL amyloidosis | Air Force Military Medical University, China | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05776940 ↗ |
| Modality | Other / unclassified | “specific probiotic” NCT05776940 ↗ |